Nyxoah SA (NYXH)
Euronext
Real-time Data
07:00 AM
Day's Range
1.3952 wk Range
1.14Overview - NYXH - Nyxoah SA
Key Statistics
Valuation
Enterprise Value
102.50M
P/E (Trailing)
‪-0.60‬
P/E (Forward)
‪-3.07‬
PEG Ratio
‪-0.12‬
Price / Sales (TTM)
‪6.67‬
Price / Book
‪1.74‬
EV / EBITDA
‪-1.23‬
Profitability
Gross Margin
‪59.72%‬
Profit Margin
‪63.13%‬
Operating Margin
‪-268.24%‬
Return on Assets
‪-36.86%‬
Return on Equity
‪-122.68%‬
Ownership
Shares Outstanding
100.07M
Float
50.88M
Held by Insiders
‪33.77%‬
Held by Institutions
‪30.43%‬
Price stats
Beta
‪0.94‬
50-Day Avg
‪1.40‬
200-Day Avg
‪2.94‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪€ 5.30‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NYXH - Nyxoah SA
Peers - NYXH - Nyxoah SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Euronext.
- NYXHEuronextNyxoah SA141.70MMarket Cap-301.84%52-week change-0.60P/E (Trailing)‪63.13%‬Profit Margin
- ELEuronextEssilorLuxottica74.31BMarket Cap-66.48%52-week change30.24P/E (Trailing)‪8.51%‬Profit Margin
- DIMEuronextSartorius Stedim Biotech S.A.18.82BMarket Cap+9.64%52-week change64.50P/E (Trailing)‪9.73%‬Profit Margin
- COVEuronextCovivio5.70BMarket Cap-12.22%52-week change8.80P/E (Trailing)‪55.91%‬Profit Margin
- SOLVEuronextSolvac S.A.1.76BMarket Cap-13.70%52-week change14.08P/E (Trailing)‪3,324,813.70%‬Profit Margin
- ALCJEuronextCrossject S.A.85.71MMarket Cap-4.20%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ALVMGEuronextVisiomed Group SA45.59MMarket Cap-37.42%52-week change51.67P/E (Trailing)‪45.95%‬Profit Margin
Profile Summary - NYXH - Nyxoah SA
About
Nyxoah SA is a medical technology company specializing in the development and commercialization of innovative solutions for treating obstructive sleep apnea (OSA). Its flagship product, the Genio system, offers a CE-marked, patient-centric, minimally invasive hypoglossal neurostimulation therapy designed for moderate…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
